Heart Failure & Transplant

Countless lives have been saved in recent years due to medical innovations including artificial hearts and mechanical circulatory support devices. Yet, heart failure continues to be one of the biggest medical problems in the world. It's time to take the next step for cardiovascular disease patients.  

Heart failure is the number one cause of hospitalization

About 6.2 million adults in the United States have heart failure, which is one of the biggest medical problems in the United States and the number one reason people are hospitalized. Due to an aging population, an increase in cardiovascular risk factors, and improved survival of cardiovascular conditions, the prevalence of heart failure is increasing worldwide.

For nearly four decades, MHIF has been at the forefront of research on innovative treatments that are changing the landscape of care for heart failure. Not only has total artificial heart technology improved since Minneapolis Heart Institute® physicians implanted the first total artificial heart in 1985, but new mechanical circulatory support devices such as the left ventricular assist device (LVAD) provide patients an opportunity for a meaningful life.

On the Pulse

Cardiac Transplantation: Past, Present & Future with Dr. Benjamin Sun

footer-image_new.jpeg

Make a Life-Changing Donation

Any gift, small or large, advances transformative research to save lives.

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.